GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.870
+0.090 (5.06%)
At close: Jul 2, 2026, 4:00 PM EDT
1.811
-0.059 (-3.17%)
After-hours: Jul 2, 2026, 7:38 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.31 million as of July 2, 2026. Its market cap has increased by 3.73% in one year.
Market Cap
3.31M
Enterprise Value
-7.68M
1-Year Change
3.73%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.31M, a decrease of -86.90%. That is a compound annual growth rate of -47.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.31M | 32.57% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 4.13M |
| Matinas BioPharma Holdings | 4.06M |
| Propanc Biopharma | 4.03M |
| Decoy Therapeutics | 3.89M |
| Artelo Biosciences | 3.87M |
| Galmed Pharmaceuticals | 3.75M |
| Onconetix | 3.53M |
| Clearmind Medicine | 3.51M |